CMC Pharmaceuticals, a provider of drug product development services, celebrated the five-year anniversary of its founding on October 3, 2019. The celebration event, hosted by CMC Pharmaceuticals at its newest laboratory location, was attended by guests from local government, customers, and suppliers, including Solon (Ohio) Mayor Ed Kraus, Solon Director of Business and Marketing, Angee Shaker, Solon Councilman, Bill Russo and 14th District Congressman David Joyce’s Representative, Katie Burger. The event included a tour of CMC Pharmaceutical’s facilities to mark the occasion.

CMC Pharmaceuticals was founded in 2014, by Dr. Mike Radomsky, based on a mission to help pharma and biotech companies, non-profit institutions, and government agencies develop high-quality drug products more efficiently. CMC Pharmaceuticals added laboratory facilities in 2015 to provide experimentally-based, data-driven development solutions to address its customer’s drug product development and manufacturing challenges. The company has grown to two laboratory locations in the Cleveland area and increased its staff from just the original founder, to now include 10 highly experienced team members with advanced scientific backgrounds.
 
The majority woman-owned business now offers fully integrated formulation development, analytical development, drug product stability, and process development services from its own R&D and current good manufacturing practices (cGMP) laboratories.
 

“The Cleveland area has been a great place to grow our business, with its central location, and highly developed medical and scientific infrastructure,” said Casey Loveland, co-founder, CMC Pharmaceuticals. “It has definitely contributed to the acceleration of our growth.”
 
Mike Radomsky, founder and president, CMC Pharmaceuticals, said, “Having started a single person consulting firm that now successfully operates as a growing organization with a wide range of global customers is a great achievement for CMC Pharmaceuticals. Over the last 5 years we’ve expanded our services and operations to meet our customer’s needs and we’ll assess new opportunities to continue that strategic growth moving forward.”